One of the deals is a six-year registry study being conduced on 400 patients by an academic institution to support a trial validating Dynamic Volume CT Technology.
Datatrak is also supporting a global pharma’s Phase III trial. At 40 trial sites Datatrak’s web-based randomisation, drug inventory, electronic data capture (EDC), medical coding and lab data import modules will be used.
After recording a small loss in the second quarter Datatrak outlined plans to differentiate itself from the dominant forces in the eClinical market by occupying a specific niche.